Mannose-binding lectin 2 secreted by hepatocellular carcinoma cells recruits and activates natural killer cells to reshape an immune-activated microenvironment
PLOS Biology · 20.05.2026 · 24 (5) · e3003793
DOI: 10.1371/journal.pbio.3003793 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 20.05.2026. Verfasst von Hangyu Liao und 11 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Gua…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Mannose-Binding Lectin, Killer Cells, Natural, Liver Neoplasms. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Crosstalk between hepatocellular carcinoma (HCC) and the tumor microenvironment (TME) is pivotal for the initiation and management of HCC. The infiltration and function of natural killer (NK) cells in the TME are frequently hindered. However, it is unclear whether a crucial regulatory factor originating from HCC cells directly modulates NK cell activity to evade immune surveillance. In this study, we found that mannose-binding lectin 2 (MBL2) expression was markedly decreased in HCC and positively correlated with HCC prognosis. MBL2 inhibited the proliferation and migration of HCC cells intracellularly. Human and murine co-culture systems of HCC and NK cells were established to demonstrate that secreted MBL2 recruited and activated NK cells in the TME, particularly upregulating the infiltration of NKp46 + NK cells. Furthermore, secreted MBL2 promoted the production of IL-13 and IL-25 by NK cells, resulting in a decrease in exhausted cytotoxic T lymphocytes. Mechanistically, MBL2 interacts with the integrin β1 receptor, activating the FAK/AKT pathway and increasing PD-L1 expression on NK cells. Our discovery identifies MBL2 as an NK cell–activating cytokine, initiating the integrin β1/FAK/AKT pathway in NK cells and reshaping an immune-activated microenvironment of HCC. Strategies to up-regulate MBL2 may enhance the anti-PD-L1 immunotherapy efficacy and serve as a potential therapeutic approach for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Live…
- Department of Pathology, Shunde Hospital of Southern Medical University, Foshan, China.
- Department of Pathology & Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
ORCID-Profile: Liang Zhao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Liao, H., Yang, J., Cai, L., Chi, L., Wang, C., Xu, Y., Xie, J., Chen, K., Pei, J., Jiang, Z., Pan, M., & Zhao, L. (2026). Mannose-binding lectin 2 secreted by hepatocellular carcinoma cells recruits and activates natural killer cells to reshape an immune-activated microenvironment. PLOS Biology, 24(5), e3003793. https://doi.org/10.1371/journal.pbio.3003793
Vancouver
Liao H, Yang J, Cai L, Chi L, Wang C, Xu Y, et al. Mannose-binding lectin 2 secreted by hepatocellular carcinoma cells recruits and activates natural killer cells to reshape an immune-activated microenvironment. PLOS Biology. 2026;24(5):e3003793. doi:10.1371/journal.pbio.3003793
BibTeX
@article{Liao2026,
author = {Liao, Hangyu and Yang, Jun and Cai, Lei and Chi, Luhao and Wang, Chunming and Xu, Yuyan and Xie, Juncheng and Chen, Kunling and Pei, Jingyuan and Jiang, Zesheng and Pan, Mingxin and Zhao, Liang},
title = {Mannose-binding lectin 2 secreted by hepatocellular carcinoma cells recruits and activates natural killer cells to reshape an immune-activated microenvironment},
journal = {PLOS Biology},
year = {2026},
volume = {24},
number = {5},
pages = {e3003793},
doi = {10.1371/journal.pbio.3003793}
}
EUVIMED